Moleculin Biotech Inc.
MBRX | NASDAQ
$0.53
+$0.01 (+1.88%)
Sep 22, 2026, 12:51 PM ET · Market open
Fiscal Year Period Ending | FY 2025 Dec 30, 2025 | FY 2024 Dec 30, 2024 | FY 2023 Dec 30, 2023 | FY 2022 Dec 30, 2022 | FY 2021 Dec 30, 2021 | FY 2020 Dec 30, 2020 |
|---|---|---|---|---|---|---|
Net Income | -33.56M | -21.76M | -29.77M | -29.03M | -15.89M | -17.36M |
Depreciation & Amortization | 90K | 126K | 127K | 130K | 164K | 200K |
Stock-Based Compensation | 1.66M | 1.73M | 1.98M | 2.28M | 2.37M | 1.68M |
Other Working Capital | -775K | 699K | 1.22M | -507K | 803K | 983K |
Other Non-Cash Items | 8.52M | -4.18M | 1.94M | -1.24M | 96K | 85K |
Deferred Income Tax | n/a | n/a | n/a | n/a | -6.73M | -2.34M |
Change in Working Capital | 555K | 231K | 1.62M | 224K | 1.04M | -41K |
Operating Cash Flow | -22.74M | -23.86M | -24.1M | -27.64M | -18.95M | -17.77M |
Capital Expenditures | n/a | -13K | -124K | -67K | -19K | -376K |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | 2K |
Purchase of Investments | n/a | n/a | n/a | n/a | n/a | n/a |
Sales Maturities Of Investments | n/a | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | n/a | n/a | n/a | n/a | n/a | n/a |
Investing Cash Flow | n/a | -13K | -124K | -67K | -19K | -374K |
Debt Repayment | n/a | n/a | n/a | n/a | n/a | n/a |
Common Stock Repurchased | n/a | n/a | n/a | -23K | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | -8K | -25K | 485K | n/a | 40K | -12K |
Financial Cash Flow | 27.28M | 4.64M | 4.65M | -23K | 74.72M | 22.55M |
Net Cash Flow | 4.6M | -19.27M | -19.6M | -27.76M | 55.73M | 4.44M |
Free Cash Flow | -22.74M | -23.88M | -24.23M | -27.71M | -18.97M | -18.15M |
Adj. Free Cash Flow | -24.4M | -25.6M | -26.21M | -29.98M | -21.34M | -19.83M |
Maintenance CapEx | n/a | -13K | -124K | -67K | -19K | -200K |
Growth CapEx | n/a | n/a | n/a | n/a | n/a | -176K |
Owner Earnings | -22.74M | -23.88M | -24.23M | -27.71M | -18.97M | -17.97M |
Add to Watchlist
Select watchlists to add or remove MBRX